Table 6. Cox proportional hazards regression model in late-stage NSCLC patients based on the Survival tree analysis.
Risk Group | Dead (N%) | Alive (N%) | HR* (95%CI) | P-value | MST# | Log-rank P value |
Chemotherapy | ||||||
Low (Node 1) | 70 (72.16) | 27 (27.84) | Reference | 13.59 | ||
Medium (Nodes 2, 4) | 183 (86.73) | 28 (13.27) | 1.55 (1.16–2.09) | 0.003 | 10.53 | |
High (Node3) | 42 (89.36) | 5 (10.64) | 2.94 (1.93–4.47) | <0.001 | 7.17 | <0.0001 |
Chemoradiation | ||||||
Low (Node 5) | 82 (74.55) | 28 (25.45) | Reference | 19.28 | ||
High (Node 6) | 22 (84.62) | 4 (15.38) | 1.89 (1.06–3.38) | 0.031 | 12.37 | 0.0055 |
*HR adjusted by age, gender, ethnicity, smoking status and pack-years, performance status, clinical stage.
#MST, median survival time (months)